Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Operating Expenses (2016 - 2025)

Pediatrix Medical (MD) has disclosed Operating Expenses for 17 consecutive years, with $445.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 3.91% to $445.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 18.09% decrease, with the full-year FY2025 number at $1.7 billion, down 18.09% from a year prior.
  • Operating Expenses was $445.0 million for Q4 2025 at Pediatrix Medical, up from $424.8 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $662.0 million in Q2 2024 to a low of $409.0 million in Q2 2025.
  • A 5-year average of $464.1 million and a median of $444.0 million in 2022 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: soared 46.44% in 2024, then plummeted 38.22% in 2025.
  • Pediatrix Medical's Operating Expenses stood at $430.5 million in 2021, then increased by 10.98% to $477.8 million in 2022, then grew by 27.23% to $607.9 million in 2023, then fell by 23.83% to $463.1 million in 2024, then decreased by 3.91% to $445.0 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Operating Expenses are $445.0 million (Q4 2025), $424.8 million (Q3 2025), and $409.0 million (Q2 2025).